Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:04 AM
Ignite Modification Date:
2025-12-25 @ 3:04 AM
NCT ID:
NCT03800433
Eligibility Criteria:
Inclusion Criteria:
* Adults (18 years or over).
* Stable hemodialysis \>6 months.
* Regular haemodialysis (3 times/ week).
* ESA resistant anemia (Hb \<10 mg/dl for 6 mo.).
* ESA dose of \>8000 IU/wk.
Exclusion Criteria:
* Inadequate hemodialysis.
* Hyperparathyroidism (PTH\>800 pg/l).
* Known hypersensitivity to, or intolerance of Pentoxifylline.
* Absolute or functional iron deficiency (ferritin \< 100 μg/L and/or transferrin saturation \< 20%).
* Presence of systemic haematological disease (including antibody-mediated pure red cell aplasia) or known haemoglobinopathy.
* Major surgery, infection, inflammatory diseases, acute myocardial infarction or malignancy within the last 3 months.
* Patients with chronic liver disease and patients who had received immunosuppressive therapy.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03800433
Study Brief:
Protocol Section:
NCT03800433